Methylnaltrexone + Placebo
Phase 3Completed 0 watching 0 views this week📈 Rising
76
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Post-Operative Ileus (POI)
Conditions
Post-Operative Ileus (POI)
Trial Timeline
Oct 31, 2006 → Feb 29, 2008
NCT ID
NCT00401375About Methylnaltrexone + Placebo
Methylnaltrexone + Placebo is a phase 3 stage product being developed by Pfizer for Post-Operative Ileus (POI). The current trial status is completed. This product is registered under clinical trial identifier NCT00401375. Target conditions include Post-Operative Ileus (POI).
Hype Score Breakdown
Clinical
27
Activity
18
Company
9
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00401375 | Phase 3 | Completed |
Competing Products
18 competing products in Post-Operative Ileus (POI)